- Home
- KPRX vs ASTC Comparison
KPRX vs ASTC Comparison
Compare KPRX & ASTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPRX
- ASTC
- Stock Information
- Founded
- KPRX 1998
- ASTC 1984
- Country
- KPRX United States
- ASTC United States
- Employees
- KPRX N/A
- ASTC N/A
- Industry
- KPRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ASTC Biotechnology: Laboratory Analytical Instruments
- Sector
- KPRX Health Care
- ASTC Industrials
- Exchange
- KPRX Nasdaq
- ASTC Nasdaq
- Market Cap
- KPRX 11.0M
- ASTC 11.9M
- IPO Year
- KPRX N/A
- ASTC 1995
- Fundamental
- Price
- KPRX $3.18
- ASTC $6.99
- Analyst Decision
- KPRX Strong Buy
- ASTC
- Analyst Count
- KPRX 1
- ASTC 0
- Target Price
- KPRX $10.00
- ASTC N/A
- AVG Volume (30 Days)
- KPRX 45.3K
- ASTC 16.3K
- Earning Date
- KPRX 11-19-2024
- ASTC 11-12-2024
- Dividend Yield
- KPRX N/A
- ASTC N/A
- EPS Growth
- KPRX N/A
- ASTC N/A
- EPS
- KPRX 1.53
- ASTC N/A
- Revenue
- KPRX $16,020,000.00
- ASTC $1,273,000.00
- Revenue This Year
- KPRX N/A
- ASTC N/A
- Revenue Next Year
- KPRX N/A
- ASTC N/A
- P/E Ratio
- KPRX $2.29
- ASTC N/A
- Revenue Growth
- KPRX N/A
- ASTC 11.96
- 52 Week Low
- KPRX $3.00
- ASTC $6.56
- 52 Week High
- KPRX $8.98
- ASTC $12.29
- Technical
- Relative Strength Index (RSI)
- KPRX 43.73
- ASTC 37.74
- Support Level
- KPRX $3.47
- ASTC $6.88
- Resistance Level
- KPRX $3.75
- ASTC $7.58
- Average True Range (ATR)
- KPRX 0.22
- ASTC 0.40
- MACD
- KPRX -0.03
- ASTC 0.01
- Stochastic Oscillator
- KPRX 0.00
- ASTC 27.59
About KPRX Kiora Pharmaceuticals Inc.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
About ASTC Astrotech Corporation (DE)
Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, and breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.